157 related articles for article (PubMed ID: 19626602)
1. Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study.
Zheng YL; Kosti O; Loffredo CA; Bowman E; Mechanic L; Perlmutter D; Jones R; Shields PG; Harris CC
Int J Cancer; 2010 May; 126(9):2199-210. PubMed ID: 19626602
[TBL] [Abstract][Full Text] [Related]
2. Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans.
Zheng YL; Loffredo CA; Alberg AJ; Yu Z; Jones RT; Perlmutter D; Enewold L; Krasna MJ; Yung R; Shields PG; Harris CC
Cancer Res; 2005 Oct; 65(20):9566-73. PubMed ID: 16230422
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer.
Buch SC; Diergaarde B; Nukui T; Day RS; Siegfried JM; Romkes M; Weissfeld JL
Mol Carcinog; 2012 Oct; 51 Suppl 1(Suppl 1):E11-20. PubMed ID: 21976407
[TBL] [Abstract][Full Text] [Related]
4. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis.
Xing J; Spitz MR; Lu C; Zhao H; Yang H; Wang W; Stewart DJ; Wu X
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1517-22. PubMed ID: 17627019
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
[TBL] [Abstract][Full Text] [Related]
7. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC
J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer.
Shao L; Hittelman WN; Lin J; Yang H; Ajani JA; Wu X
Mutat Res; 2006 Dec; 602(1-2):143-50. PubMed ID: 17011594
[TBL] [Abstract][Full Text] [Related]
9. The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations.
Hall J; Marcel V; Bolin C; Fernet M; Tartier L; Vaslin L; Hainaut P
Biochem Soc Trans; 2009 Jun; 37(Pt 3):527-33. PubMed ID: 19442246
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk.
Wu X; Roth JA; Zhao H; Luo S; Zheng YL; Chiang S; Spitz MR
Cancer Res; 2005 Jan; 65(1):349-57. PubMed ID: 15665313
[TBL] [Abstract][Full Text] [Related]
11. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
13. Genetic factors in individual radiation sensitivity.
Hornhardt S; Rößler U; Sauter W; Rosenberger A; Illig T; Bickeböller H; Wichmann HE; Gomolka M
DNA Repair (Amst); 2014 Apr; 16():54-65. PubMed ID: 24674628
[TBL] [Abstract][Full Text] [Related]
14. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study.
Hung RJ; Brennan P; Canzian F; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Borel S; Hall J; Boffetta P
J Natl Cancer Inst; 2005 Apr; 97(8):567-76. PubMed ID: 15840879
[TBL] [Abstract][Full Text] [Related]
15. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer.
Zhao H; Spitz MR; Tomlinson GE; Zhang H; Minna JD; Wu X
Cancer Res; 2001 Nov; 61(21):7819-24. PubMed ID: 11691798
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
17. The Saccharomyces cerevisiae checkpoint genes RAD9, CHK1 and PDS1 are required for elevated homologous recombination in a mec1 (ATR) hypomorphic mutant.
Fasullo M; Sun M
Cell Cycle; 2008 Aug; 7(15):2418-26. PubMed ID: 18677117
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
19. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
Lo YL; Hsiao CF; Jou YS; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hsieh WS; Chen CJ; Hsiung CA
Lung Cancer; 2011 Jun; 72(3):280-6. PubMed ID: 21093954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
